Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) Times Interest Earned (2019 - 2026)

Alx Oncology Holdings' Times Interest Earned history spans 4 years, with the latest figure at $213.22 for Q4 2023.

  • On a quarterly basis, Times Interest Earned fell 28.93% to $213.22 in Q4 2023 year-over-year; TTM through Dec 2023 was -$21.58, a 80.19% increase, with the full-year FY2025 number at -$13.33, up 83.82% from a year prior.
  • Times Interest Earned hit $213.22 in Q4 2023 for Alx Oncology Holdings, up from -$136.25 in the prior quarter.
  • Over the last five years, Times Interest Earned for ALXO hit a ceiling of $7416.0 in Q4 2019 and a floor of -$18340.5 in Q3 2022.
  • Historically, Times Interest Earned has averaged -$3136.2 across 4 years, with a median of -$98.86 in 2023.
  • Biggest five-year swings in Times Interest Earned: crashed 143.91% in 2020 and later skyrocketed 99.41% in 2023.
  • Tracing ALXO's Times Interest Earned over 4 years: stood at $7416.0 in 2019, then tumbled by 143.91% to -$3256.6 in 2020, then soared by 109.21% to $300.0 in 2022, then dropped by 28.93% to $213.22 in 2023.
  • Business Quant data shows Times Interest Earned for ALXO at $213.22 in Q4 2023, -$136.25 in Q3 2023, and -$98.86 in Q2 2023.